How Can Ulcerative Colitis Affect Your Cholesterol? How Can Ulcerative Colitis Affect Your Cholesterol?
A new study from researchers in the Netherlands found that IBD patients ' cardiovascular risk factors may be underestimated because of the absence of things like high cholesterol.WebMD Health News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 29, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
How Can Ulcerative Colitis Affect Your Cholesterol? What to Know
UC patients not only have to deal with treating and managing gastrointestinal problems related to their IBD – they’re also at higher risk for cardiovascular disease. Here's what to know. (Source: WebMD Health)
Source: WebMD Health - June 29, 2023 Category: Consumer Health News Source Type: news
Mirikizumab Benefit in UC Extends Into Maintenance Phase
(MedPage Today) -- The investigational monoclonal antibody mirikizumab was more effective in inducing and maintaining clinical remission in patients with moderate to severe ulcerative colitis (UC) compared with placebo, according to two phase III... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 29, 2023 Category: Gastroenterology Source Type: news
Effectiveness of Golimumab Intensification in Ulcerative Colitis Effectiveness of Golimumab Intensification in Ulcerative Colitis
Nearly 40% of patients with ulcerative colitis eventually fail to respond to golimumab treatment. Can therapeutic drug intensification recapture response?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 20, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Herbal Combo Shows Promise in Active Ulcerative Colitis Herbal Combo Shows Promise in Active Ulcerative Colitis
Curcumin plus Qing Dai was effective for inducing response and remission in patients with active ulcerative colitis in a small placebo-controlled trial.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - June 15, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
With Moderna windfall, Harvard professor and integrins legend Tim Springer donates $210M to his Institute for Protein Innovation
Tim Springer, with his name stapled to the likes of Moderna, Scholar Rock and Editas Medicine, plus the foundational work for Takeda’s ulcerative colitis and Crohn’s disease med Entyvio, has had a lot on his plate over the past five decades. In 2020, the Harvard professor became a billionaire…#timspringer #moderna #scholarrock #takeda #crohn #harvard #leukosite (Source: Reuters: Health)
Source: Reuters: Health - May 24, 2023 Category: Consumer Health News Source Type: news
Warning: Prior Auth for Colonoscopy Is the Wrong Way to Go
(MedPage Today) -- Two weeks ago, I saw my 39-year-old patient with long-standing ulcerative colitis in clinic for new onset bleeding per rectum. She mentioned needing to attend an upcoming conference, and was eager to get to the source of the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 24, 2023 Category: American Health Source Type: news
Tofacitinib De-escalation in UC: Proceed With Caution Tofacitinib De-escalation in UC: Proceed With Caution
Patients with ulcerative colitis who de-escalate tofacitinib therapy may experience a disease flare, and not all will recapture clinical response with dose re-escalation, real-world data show.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 21, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Meat-Heavy Diets May Lead to Ulcerative Colitis Flares Meat-Heavy Diets May Lead to Ulcerative Colitis Flares
Patients with ulcerative colitis and meat-heavy diets had twice as many flares as those who ate less meat.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 18, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
21-year-old's sudden pain turned out to be life-changing illness - signs to spot
Admin manager, Kirsty Heron, has been left in agonising pain and unable to live her life after being diagnosed with ulcerative colitis. (Source: Daily Express - Health)
Source: Daily Express - Health - May 15, 2023 Category: Consumer Health News Source Type: news
Etrasimod Looks Safe for Ulcerative Colitis Out to 2.5 Years Etrasimod Looks Safe for Ulcerative Colitis Out to 2.5 Years
Experts recommend an electrocardiogram to screen for some heart-related risks before prescribing.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 12, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Small Increase in Lymphoma Risk Seen With Crohn Disease, Ulcerative Colitis
WEDNESDAY, May 10, 2023 -- Crohn disease (CD) and ulcerative colitis (UC) are associated with a slightly increased risk for lymphoma, according to a study published online April 13 in Clinical Gastroenterology and Hepatology.
Ola Olén M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 10, 2023 Category: Pharmaceuticals Source Type: news
First Phase 3 TREMFYA ® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, May 9, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new efficacy and safety data from the Phase 3 QUASAR Induction Study evaluating the investigational use of TREMFYA® (guselkumab) in adults with moderately to severely active ulcerative colitis (UC)a who had an inadequate response or intolerance to conventionalb and/or advanced therapies.1,c The data show statistically significant and clinically meaningful improvements across symptomatic and histo-endoscopic outcome measures.1 Safety data were also consistent with the known safety profile of TREMFYA in ...
Source: Johnson and Johnson - May 9, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Excerpt: Elevating Ulcerative Colitis Treatment Expectations - Rethinking Remission and Treatment Goals with Dr. David T. Rubin Excerpt: Elevating Ulcerative Colitis Treatment Expectations - Rethinking Remission and Treatment Goals with Dr. David T. Rubin
Excerpt: Rethinking Remission and Treatment Goals with Dr. David T. RubinMedscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 1, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
Cochrane study finds stool transplants more effective than antibiotics for treating recurring, life-threatening gut infections
A new Cochrane Review has found that, compared with standard antibiotic treatment, stool transplantation can increase the number of people recovering from Clostridioides difficile (C. diff) infection, a condition which causes potentially life-threatening diarrhea. 77 percent of people who received a stool transplant did not experience reinfection within eight weeks, compared to 40 percent of those who received antibiotics alone.C. diff is a bacterium that can cause life-threatening diarrheal illness in individuals with an unhealthy mixture of gut bacteria, known as dysbiosis. The most common cause of dysbiosis is treatment...
Source: Cochrane News and Events - April 24, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news
